CNS pipeline · person
Roger Adsett, MBA
Board Director of Definium Therapeutics, appointed January 2026. A biopharmaceutical executive with over two decades of experience; currently Chief Operating Officer at Insmed (previously its Chief Commercial Officer), with prior senior commercial roles at Shire and AstraZeneca. MBA from the Wharton School.
- 1 company
Courtesy Definium Therapeutics
Current roles
- Definium Therapeutics, Inc.Board Director · Board
Appears with
People sharing a company with Roger.
- Andreas Krebs · Definium Therapeutics, Inc.
- Brandi Roberts · Definium Therapeutics, Inc.
- Carol A. Vallone · Definium Therapeutics, Inc.
- Daniel R. Karlin · Definium Therapeutics, Inc.
- Gregg Pratt · Definium Therapeutics, Inc.
- Mark Sullivan · Definium Therapeutics, Inc.
- Matt Wiley · Definium Therapeutics, Inc.
- Maurizio Fava · Definium Therapeutics, Inc.
- Robert Barrow · Definium Therapeutics, Inc.
- Robert C. Malenka · Definium Therapeutics, Inc.
- Stephanie Fagan · Definium Therapeutics, Inc.
- Suzanne Bruhn · Definium Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.